Peter Altman

Peter Altman is an accomplished CEO and Board Member with a rich background in biotechnology, diagnostics, and medical devices.

His expertise spans various domains including financing, regulatory strategy, clinical development, intellectual property, and business development and licensing.

He is committed to continuous self-improvement and excels in team leadership and building.

Peter's educational journey includes a Management of Technology degree from the University of California, Berkeley, Haas School of Business, as well as a PhD in Bioengineering/Pharmaceutical Chemistry from the University of California, San Francisco.

Additionally, he holds a Doctor of Philosophy in Corneal Biomechanics from Columbia University in New York City and a Master of Science in Thermofluid Sciences, Mechanical Engineering from Columbia Engineering.

Peter Altman's academic background also features a Bachelor of Science in Mechanical Engineering Design from Columbia University's Fu Foundation School of Engineering and Applied Science.

He has held key positions in prominent organizations, serving as a Board Member at OncoCyclist Biotech and previously as CEO of BioCardia.

Prior to that, he held the roles of CEO and Director at Lumen Therapeutics and CareDx, Inc. Peter also contributed his expertise as a Senior Research and Development Engineer at St. Jude Medical and as an Experimental Cardiology Research Engineer at St. Luke's Roosevelt Hospital.